Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Curacyte ag – product pipeline review – 2012


Published on announce The Latest report -Curacyte AG – Product Pipeline Review – 2012

  • Be the first to comment

  • Be the first to like this

Curacyte ag – product pipeline review – 2012

  1. 1. announces, The Latest market research report is available inits vast collection:Curacyte AG – Product Pipeline Review – 2012 link of Global Markets Direct Market Direct’s pharmaceuticals report, “Curacyte AG - Product PipelineReview - 2012” provides data on the Curacyte AG’s research and development focus.The report includes information on current developmental pipeline, complete withlatest updates, and features on discontinued and dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Curacyte AG’s corporate website, SEC filings, investorpresentations and featured press releases, both from Curacyte AG and industry-specific third party sources, put together by Global Markets Direct’s team.Scope- Curacyte AG - Brief Curacyte AG overview including business description, keyinformation and facts, and its locations and subsidiaries.- Review of current pipeline of Curacyte AG human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:
  2. 2. List of Tables 4List of Figures 4Curacyte AG Snapshot 5Curacyte AG Overview 5Key Information 5Key Facts 5Curacyte AG – Research and Development Overview 6Key Therapeutic Areas 6Curacyte AG – Pipeline Review 8Pipeline Products by Stage of Development 8Pipeline Products – Monotherapy 9Curacyte AG – Pipeline Products Glance 10Curacyte AG Clinical Stage Pipeline Products 10Phase II Products/Combination Treatment Modalities 10Curacyte AG – Early Stage Pipeline Products 11Pre-Clinical Products/Combination Treatment Modalities 11Discovery Products/Combination Treatment Modalities 12Curacyte AG – Drug Profiles 13CD 160130 13Product Description 13Mechanism of Action 13R&D Progress 13Hemoximer 14Product Description 14Mechanism of Action 14R&D Progress 14Plasmin And Plasma Kallikrein Inhibitor 16Product Description 16Mechanism of Action 16R&D Progress 16Protease Inhibitors 17Product Description 17Mechanism of Action 17List of Figures
  3. 3. List of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012 PipelineReview&PubId=&pagenum=1Cellceutix Pharmaceuticals, Inc. – Product Pipeline Review – 2012Ceregene, Inc. – Product Pipeline Review – 2012Curacyte AG – Product Pipeline Review – 2012DEKK-TEC, Inc. – Product Pipeline Review – 2012Egalet Ltd. – Product Pipeline Review – 2012Fresenius Biotech GmbH – Product Pipeline Review – 2012Evolva SA – Product Pipeline Review – 2012Glycotope GmbH – Product Pipeline Review – 2012Hawthorn Pharmaceuticals, Inc. – Product Pipeline Review – 2012Helsinn Healthcare S.A. – Product Pipeline Review – 2012Hygeia Therapeutics, Inc. – Product Pipeline Review – 2012IkerChem S.L. – Product Pipeline Review – 2012
  4. 4. Search More Reports Related to This Category :Pharmaceuticals and Healthcare andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: